🇺🇸 FDA
Pipeline program

INZ-701, INZ-701

INZ701-104

Phase 1 small_molecule active

Quick answer

INZ-701, INZ-701 for Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency or ATP-binding Cassette Sub-family C Member 6 (ABCC6) Deficiency is a Phase 1 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency or ATP-binding Cassette Sub-family C Member 6 (ABCC6) Deficiency
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials